{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06144619",
            "orgStudyIdInfo": {
                "id": "MCC-22098"
            },
            "organization": {
                "fullName": "H. Lee Moffitt Cancer Center and Research Institute",
                "class": "OTHER"
            },
            "briefTitle": "Non-Invasive Biomarkers in Prostate Cancer Disease Management",
            "officialTitle": "Non-Invasive Biomarkers in Prostate Cancer Disease Management",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "non-invasive-biomarkers-in-prostate-cancer-disease-management"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-11-21",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2029-01-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-01-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-11-16",
            "studyFirstSubmitQcDate": "2023-11-16",
            "studyFirstPostDateStruct": {
                "date": "2023-11-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-08",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-09",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "H. Lee Moffitt Cancer Center and Research Institute",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is an observational retrospective/ prospective study with diagnosed low/intermediate risk (no-surgery) \\& high risk (surgery) prostate cancer that are eligible and willing to undergo standard of care (SOC) assessment, annually along with biopsies, bio-fluid collection. Participants will obtain genomic and histological evaluation on their biopsied samples. Study follows SOC collection with additional body fluid collection (blood, urine). Biopsy/surgery will not require additional sample collection"
        },
        "conditionsModule": {
            "conditions": [
                "Prostate Cancer"
            ],
            "keywords": [
                "Intermediate Risk Prostate Cancer",
                "High Risk Prostate Cancer"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 500,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Intermediate risk group (no-surgery)",
                    "description": "Participants diagnosed with pre-biopsy mpMRI.",
                    "interventionNames": [
                        "Genetic: Genomic and Histological Evaluation"
                    ]
                },
                {
                    "label": "High-risk group (surgery)",
                    "description": "Participants who had radical prostatectomy (RP) with (or with-out) mpMR imaging.",
                    "interventionNames": [
                        "Genetic: Genomic and Histological Evaluation"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "GENETIC",
                    "name": "Genomic and Histological Evaluation",
                    "description": "Participants will obtain genomic and histological evaluation on their biopsied samples. (Follows SOC)",
                    "armGroupLabels": [
                        "High-risk group (surgery)",
                        "Intermediate risk group (no-surgery)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Disease Progression",
                    "description": "Progression will be defined according to the National Comprehensive Cancer Network (NCCN) clinical guidelines.\n\nIntermediate risk group (no-surgery): Evaluation of targeted lesion indicates any one of the following: a) Gleason grade group of 2 or 3 (Gleason Score: 3+4 or 4+3), b) re-biopsy of lesion results in higher Gleason grade, initial GS 3+3 becomes a 3+4 or higher and c) secondary end point include clinical progression assessed by radiological progression (increased PIRADS score) and/or serum progression (PSA increase).\n\nHigh risk group (surgery): Participants who undergo prostatectomy as standard of care recommendation, following the NCCN guidelines. Participants in this group fall under these clinical characteristics: a) unfavorable intermediate-risk: biopsies with GS 4+3 or higher, b) high risk for prostate cancer progression: biopsies with GS 4+4 or greater or cT3 or greater disease, c) Progression following treatment, increase in PSA (",
                    "timeFrame": "Up to 3 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Prostate cancer patients who had received primary diagnosis at Moffitt or outside the cancer center with available records (radiology, pathology, access to samples).\n* No-Surgery (Intermediate risk) group: patients diagnosed with pre-biopsy mpMRI, blood plasma: the biopsy must consist of a pathological diagnosis with a Gleason pattern score.\n* Surgery (High risk) group: patients who had radical prostatectomy (RP) with (or with-out) mpMR imaging, bio fluids available for research will be accrued for this group. We follow the NCCN recommendations for high-risk (Unfavorable intermediate risk or High-risk) groups inclusion and follow-up criteria (58, 89, 90).\n* \u2265 4 ng/ml and \u2264 20 ng/ml and PSA \u2264 10 ng/ml (for late disease), within 3 months of study enrollment.\n* Age 35 through 85 years.\n* Zubrod/ECOG performance status \\<2;\n* Ability to understand and willingness to sign a written informed consent document.\n* Patients who agree to have a multiparametric MRI with targeted/template biopsy.\n* Patients must agree to fill out the longitudinal psychosocial questionnaires assessing health related quality of life.\n* Availability of Bio-samples (blood plasma, urine) for exosomal, proteomic, genomic and pathology (H\\&E slides, IHC slides).\n* Quantity of bio-samples; Blood, Urine, tissue sections (including FFPE) for each region of interest.\n\nExclusion Criteria:\n\n* Subject is not a candidate for multiparametric MRI with contrast. Some reasons may include (but are not limited to): renal insufficiency, foreign body or pacemakers.\n* No prior pelvic radiotherapy\n* No prior surgery to the prostate, other than transurethral procedures for benign prostatic hyperplasia (e.g., transurethral resection, green light laser treatment)\n* No concurrent, active malignancy, other than non-metastatic skin cancer of any type, superficial bladder cancer, or early-stage chronic lymphocytic leukemia (well-differentiated small cell lymphocytic lymphoma) or \\> Bilateral hip replacement.",
            "healthyVolunteers": false,
            "sex": "MALE",
            "minimumAge": "35 Years",
            "maximumAge": "85 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Prostate cancer patients who had received primary diagnosis at Moffitt or outside the cancer center with available records (radiology, pathology, access to tissue samples).",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Yoganand Balagurunathan, PhD",
                    "role": "CONTACT",
                    "phone": "813-745-1376",
                    "email": "Yoganand.Balagurunathan@moffitt.org"
                },
                {
                    "name": "Julio Pow-Sang, MD",
                    "role": "CONTACT",
                    "phone": "813-745-2226",
                    "email": "Julio.Powsang@moffitt.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Yoganand Balagurunathan, PhD",
                    "affiliation": "Moffitt Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Julio Pow-Sang, MD",
                    "affiliation": "Moffitt Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Moffitt Cancer Center",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Yoganand Balagurunathan, PhD",
                            "role": "CONTACT",
                            "phone": "813-745-1376",
                            "email": "Yoganand.Balagurunathan@moffitt.org"
                        },
                        {
                            "name": "Yoganand Balagurunathan, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Julio Pow-Sang, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Liang Wang, PhD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Kenneth Gage, MD, PhD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000011471",
                    "term": "Prostatic Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005834",
                    "term": "Genital Neoplasms, Male"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000005832",
                    "term": "Genital Diseases, Male"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000011469",
                    "term": "Prostatic Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M14335",
                    "name": "Prostatic Neoplasms",
                    "asFound": "Prostate Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8946",
                    "name": "Genital Neoplasms, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8944",
                    "name": "Genital Diseases, Male",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14333",
                    "name": "Prostatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}